Criteria to qualify for study: | Drug used in study: |
---|---|
|
CLL46 A Phase 1/2 Multicenter study evaluating the safely and efficacy of KTE-C19 in adult subjects with relapsed/refractory Chronic Lymphocytic Lymphoma. |
Criteria to qualify for study: | Drug used in study: |
---|---|
|
MDS 21 |